FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225134857> ?p ?o ?g. }

• W4225134857 endingPage "103696" @default.
• W4225134857 startingPage "103696" @default.
• W4225134857 abstract "The high burden of hepatitis C among people who inject drugs in Australia underscores the need to increase testing within this population. Understanding hepatitis C screening uptake in primary care settings is therefore critical to the development of effective and targeted strategies to improve hepatitis C testing for people who inject drugs. Primary care services that prescribe OAT are well-positioned to provide hepatitis C testing among a priority population at-risk of hepatitis C.This study used linked data from 5,429 individuals attending ten clinical services participating in the Australian Collaboration for Coordinated Enhanced Sentinel Surveillance (ACCESS) who received their first recorded OAT prescription between 1st January 2012 and 31st December 2019. We estimated the proportion of OAT recipients who received a hepatitis C antibody test within 12 months of their first recorded OAT prescription, and the proportion of individuals tested who received a positive hepatitis C antibody test.Approximately one in five individuals (17%) received a hepatitis C antibody test in the 12 months following their first recorded OAT prescription. Over half of individuals tested (56%) received a positive hepatitis C antibody test result. Hepatitis C antibody testing was higher among individuals who attended 5-8 (aOR:2.98; 95%CI:2.41-3.69) and 9+ (aOR:6.17; 95%CI:5.13-7.43) clinical consultations, were women (aOR:1.20; 95%CI:1.08-1.34) and whose first recorded OAT prescription occurred in 2017 vs. 2012 (aOR:1.39; 95%CI:1.06-1.84). Hepatitis C antibody testing was lower among individuals prescribed methadone (aOR:0.81; 95%CI:0.73-0.91), and individuals aged 60+ years vs. 18-29 years (aOR:0.67; 95%CI:0.48-0.94).Despite high positivity rates, hepatitis C antibody testing among individuals prescribed OAT remains low. There are opportunities for increased testing among populations exhibiting greater proportions of missed testing opportunities. Integrating routine hepatitis C screening in OAT settings will likely increase case-finding and contribute to Australia's hepatitis C elimination targets." @default.
• W4225134857 created "2022-05-01" @default.
• W4225134857 creator A5000827643 @default.
• W4225134857 creator A5013176250 @default.
• W4225134857 creator A5026835706 @default.
• W4225134857 creator A5036397431 @default.
• W4225134857 creator A5037317469 @default.
• W4225134857 creator A5044199455 @default.
• W4225134857 creator A5064017095 @default.
• W4225134857 creator A5070072709 @default.
• W4225134857 creator A5076004104 @default.
• W4225134857 creator A5076194922 @default.
• W4225134857 creator A5076813649 @default.
• W4225134857 creator A5079344044 @default.
• W4225134857 creator A5080999757 @default.
• W4225134857 date "2022-06-01" @default.
• W4225134857 modified "2023-10-06" @default.
• W4225134857 title "Hepatitis C antibody testing among opioid agonist therapy recipients, Victoria, Australia, 2012 to 2020" @default.
• W4225134857 cites W1727788371 @default.
• W4225134857 cites W1988316103 @default.
• W4225134857 cites W2050747864 @default.
• W4225134857 cites W2059950149 @default.
• W4225134857 cites W2072257689 @default.
• W4225134857 cites W2167150962 @default.
• W4225134857 cites W2468107072 @default.
• W4225134857 cites W2602169852 @default.
• W4225134857 cites W2765348434 @default.
• W4225134857 cites W2884203623 @default.
• W4225134857 cites W2913713532 @default.
• W4225134857 cites W2938693571 @default.
• W4225134857 cites W2940255242 @default.
• W4225134857 cites W2987157692 @default.
• W4225134857 cites W3006704404 @default.
• W4225134857 cites W3011049419 @default.
• W4225134857 cites W3024076667 @default.
• W4225134857 cites W3119473535 @default.
• W4225134857 cites W3150428926 @default.
• W4225134857 doi "https://doi.org/10.1016/j.drugpo.2022.103696" @default.
• W4225134857 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35490624" @default.
• W4225134857 hasPublicationYear "2022" @default.
• W4225134857 type Work @default.
• W4225134857 citedByCount "1" @default.
• W4225134857 countsByYear W42251348572023 @default.
• W4225134857 crossrefType "journal-article" @default.
• W4225134857 hasAuthorship W4225134857A5000827643 @default.
• W4225134857 hasAuthorship W4225134857A5013176250 @default.
• W4225134857 hasAuthorship W4225134857A5026835706 @default.
• W4225134857 hasAuthorship W4225134857A5036397431 @default.
• W4225134857 hasAuthorship W4225134857A5037317469 @default.
• W4225134857 hasAuthorship W4225134857A5044199455 @default.
• W4225134857 hasAuthorship W4225134857A5064017095 @default.
• W4225134857 hasAuthorship W4225134857A5070072709 @default.
• W4225134857 hasAuthorship W4225134857A5076004104 @default.
• W4225134857 hasAuthorship W4225134857A5076194922 @default.
• W4225134857 hasAuthorship W4225134857A5076813649 @default.
• W4225134857 hasAuthorship W4225134857A5079344044 @default.
• W4225134857 hasAuthorship W4225134857A5080999757 @default.
• W4225134857 hasConcept C126322002 @default.
• W4225134857 hasConcept C159654299 @default.
• W4225134857 hasConcept C203014093 @default.
• W4225134857 hasConcept C2426938 @default.
• W4225134857 hasConcept C2775876817 @default.
• W4225134857 hasConcept C2776029263 @default.
• W4225134857 hasConcept C2776455275 @default.
• W4225134857 hasConcept C2777382497 @default.
• W4225134857 hasConcept C2908647359 @default.
• W4225134857 hasConcept C71924100 @default.
• W4225134857 hasConcept C98274493 @default.
• W4225134857 hasConcept C99454951 @default.
• W4225134857 hasConceptScore W4225134857C126322002 @default.
• W4225134857 hasConceptScore W4225134857C159654299 @default.
• W4225134857 hasConceptScore W4225134857C203014093 @default.
• W4225134857 hasConceptScore W4225134857C2426938 @default.
• W4225134857 hasConceptScore W4225134857C2775876817 @default.
• W4225134857 hasConceptScore W4225134857C2776029263 @default.
• W4225134857 hasConceptScore W4225134857C2776455275 @default.
• W4225134857 hasConceptScore W4225134857C2777382497 @default.
• W4225134857 hasConceptScore W4225134857C2908647359 @default.
• W4225134857 hasConceptScore W4225134857C71924100 @default.
• W4225134857 hasConceptScore W4225134857C98274493 @default.
• W4225134857 hasConceptScore W4225134857C99454951 @default.
• W4225134857 hasLocation W42251348571 @default.
• W4225134857 hasLocation W42251348572 @default.
• W4225134857 hasOpenAccess W4225134857 @default.
• W4225134857 hasPrimaryLocation W42251348571 @default.
• W4225134857 hasRelatedWork W1868871444 @default.
• W4225134857 hasRelatedWork W2018512112 @default.
• W4225134857 hasRelatedWork W2020144630 @default.
• W4225134857 hasRelatedWork W2039739117 @default.
• W4225134857 hasRelatedWork W2074112159 @default.
• W4225134857 hasRelatedWork W2147017233 @default.
• W4225134857 hasRelatedWork W2373277990 @default.
• W4225134857 hasRelatedWork W3157139424 @default.
• W4225134857 hasRelatedWork W4210254196 @default.
• W4225134857 hasRelatedWork W4300054035 @default.
• W4225134857 hasVolume "104" @default.
• W4225134857 isParatext "false" @default.
• W4225134857 isRetracted "false" @default.

• next